INTRODUCTION {#S1}
============

Febrile convulsion is the most common type of seizure in children between 3-60 months old ([@R1]-[@R2]). Its frequency is 2-5% ([@R3]). In recent years, multiple investigations have been conducted to evaluate the role of viral infections in developing febrile convulsion ([@R4]). Among viral infections, HHV-6 has been considered as a probable cause of febrile convulsion and its prevalence evaluated in various areas in the world ([@R4]-[@R7]).

Roseola infantum or exanthem subitum is a common infection due to HHV-6 in the infants. Classic form of roseola infantum is high grade fever that lasts for 3-5 days and maculopapular rash that appears subsequently after subsiding fever. This classic manifestation only appears in 15% of patients and mostly nonspecific manifestations such as fever, rhinorrhea, cough, seizure, irritability, lymphadenopathy and nausea develop ([@R6]-[@R8]). Previous studies showed that febrile convulsion is common during exanthem subitum ([@R9]). For many years, investigators believed that fever is the cause of seizure in this infection, but recent studies have shown that HHV-6 is able to involve the central nervous system during roseola disease ([@R10], [@R11]).

The aim of this research was to determine the prevalence of HHV-6 in children with febrile convulsion using PCR method for detection of HHV-6 DNA in cerebrospinal fluid (CSF).

MATERIALS AND METHODS {#S2}
=====================

Sample collection {#S3}
-----------------

In this descriptive cross sectional study, 100 children younger than 2 years of age with febrile convulsion were enrolled. They were referred to emergency ward in Pediatric Medical Center. After obtaining informed consent from parents, cerebrospinal fluid was obtained from all of them and evaluated for analysis and detecting HHV-6 by PCR method in Virology Department of Tehran University of Medical Sciences.

Molecular assays {#S4}
----------------

DNA was extracted from 150 μL of samples using the Roche extraction kit according to the manufacturer's instruction. Primers designed based on conserved part of U22 gene of HHV-6 genome. Forward primer: 5′-TCGAAATAAGCATTAATAGGCACACT-3′and Reverse primer: 5′- CGGAGTTAAGGCATTGGTTGA-3′. Each 50 μl PCR mixture contained 5 μl of 10X PCR buffer, 2 μl Mgcl2 50 mM, 1 μl dNTPs 10mM, 2.5 μl of each of the primers with 10pmol/ μl concentration, 0.4 μl of Taq DNA polymerase, 31.5 μl ddH2O and 5 μl of extracted DNA. The amplification process was conducted under following conditions: 94°C for 6 min; then 40 cycles of 94°C for 30s, 55°C for 30s, and 72°C for 45s; and finally 72°C for 7 min. Positive control was purchased from Vircell company.

Statistical method {#S5}
------------------

General information and laboratory findings were collected in questionnaires and finally data were analyzed by SPSS-13.

RESULTS {#S6}
=======

100 children younger than 2 years old were evaluated. They had referred to Pediatric Medical Center with fever and convulsion. All of them were undergone lumbar puncture for ruling out meningitis and encephalitis. HHV-6 was detected from CSF in six patients (6%) by PCR method. General information and laboratory findings on blood and CSF in all studied patients as well as HHV-6 positive patients have been shown in [Table 1](#T1){ref-type="table"}.

Fifteen percent of patients had history of previous seizure. Six patients (6%) had seizure about 48 hours before fever. Seven patients (7%) had vaccination about 48 hours before febrile convulsion including six cases with MMR vaccination and one child with influenza vaccination. Two cases (2%) had rash at the time of febrile convulsion. Gram positive diplococi was found in CSF Gram staining in only one case.

In Five patients (83.4%) with roseola, seizure was generalized tonic clonic whereas 1 case (16.6%) had atonic seizure. In the patients with HHV-6 positive all were younger than 12 months old and the youngest patient was 4 months old. Exanthem subitus (classic rash for roseola infantum) was not manifested in the patients.

DISCUSSION {#S7}
==========

HHV-6 infection mostly occurs in early years of life. It\'s most common manifestations are fever, rash and seizure ([@R6]). HHV-6 primary infection is associated with 10-20% of febrile convulsions in infants. Most of them did not experience rash. HHV-6 DNA was detected in CSF of 6% children and adults with focal encephalitis with unknown origin ([@R6]).

In this study HHV-6 DNA was detected from 6% of CSF specimens obtained from 100 children younger than 2 years old who were referred to Pediatric Medical Center. The results were similar to several investigations in various areas worldwide. For instance, Ward and coworkers studied 200 children younger than 2 years old with primary HHV-6 infection. They detected HHV-6 DNA from CSF in 7% of cases ([@R6]). Of course, in some studies the prevalence of HHV-6 has been lower or higher than this study. For example , in Tavakoli & Hull study in 2007, prevalence of HHV-6 DNA positivity in 1482 CSF samples obtained from cases with meningitis or encephalitis was reported to be 1.75% ([@R7]). Also, in some investigations such as Bertolani study, 35% of patients with febrile convulsion were positive for HHV-6 ([@R12]). Similar to other investigations, none of the patients with febrile convulsion and HHV-6 had exanthema subitus. The results of this research were comparable with other studies which showed the peak acquisition of primary HHV6 infection, from 6 to 15 months of age. Before 6 months of age, there was a low rate (\<10%) of primary HHV6 infection ([@R6]).

In present study, mean of WBC was 12000 cell/mL with a relative lymphocytosis. One of studied cases has significant poleocytosis with predominacy of lymphocyte in CSF. In Roseola, WBC counts of 8000 - 9000 cell/ml may be found during the first few days of fever in children. The CSF in children with HHV6 associated febrile seizures typically is normal. The CSF from rare cases of HHV6 associated meningoencephalitis and encephalitis is characterized by a mild pleocytosis with predominance of mononuclear cells, normal glucose and normal to slightly elevated protein ([@R6]).

In Yoshikawa study in 2009, 86 cases with exanthema subitum and encephalitis/encephalopathy were evaluated and HHV-6 DNA was detected in 21 patients ([@R13]).

In present study all of our patients survived and we had no death whereas in Yoshikawa study 2 cases of death occurred among 86 cases ([@R13]). In another study on 138 patients with encephalitis, 9 cases Were HHV-6 positive which four of them had complete recovery, 3 cases had neurological complications, one case had status epilepticus and one case died ([@R14]).

Suga and colleagues evaluated 21 children with HHV-6 infection and neurological complications (seizure and encephalitis). In their study HHV-6 DNA was detected in CSF by PCR method in 3 cases. One of them died immediately after admission and seizure was remained in one case as a complication ([@R15]).

Finally this study was a cross sectional descriptive study on immunocompetent children.

The results of our investigation would help us to decide about applying molecular tests as a diagnostic method in pediatric febrile convulsion. Also, the results on these expectations would help us to use antibiotics rationally in the febrile convulsion.

According to this study and the prevalence of roseola infantum in the children with febrile convulsion evaluation of CSF (detecting HHV-6 DNA by PCR) is recommended in children younger than 12 months old who admitted with febrile convulsion.

Further studies on immunocompromised children are recommended for comparing results in immunocompetent and immunocompromised children. Because our sample size was small, more studies with larger number of participants are recommended for achieving more accurate results. Also, regarding to low frequency of bacterial meningitis in febrile convulsion cases, it is recommended to avoid irrational prescribed antibiotics.

In conclusion these findings showed that primary infection with HHV-6 is frequently associated with febrile convulsion in infants which may be a risk factor for subsequent development of epilepsy.
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###### 

General information and laboratory findings of all studied patients.

  variables                                                       All children with febrile convulsion (n = 100)   Children with HHV-6 PCR positive (n = 6)
  --------------------------------------- ----------------------- ------------------------------------------------ ------------------------------------------
  Gender                                  Male                    59 (59%)                                         6 (100%)
  Female                                  41 (41%)                0 (0%)                                           
  Mean of age                                                     11 months                                        8 months
  Season                                  Spring                  15 (15%)                                         0 (0%)
  Summer                                  5 (5%)                  1 (16.6%)                                        
  Fall                                    43 (43%)                2 (33.3%)                                        
  Winter                                  37 (37%)                3 (50%)                                          
  Primary manifestations                  Fever                   98 (98%)                                         6 (100%)
  Fever and diarrhea                      13 (13%)                0 (0%)                                           
  Fever and vomiting                      8 (8%)                  0 (0%)                                           
  Fever and cough                         19 (19%)                1 (16.6%)                                        
  Fever and coryza                        14 (14%)                1 (16.6%)                                        
  Episode of seizure                      One episode             81 (81%)                                         5 (83.3%)
  More than one episode                   19 (19%)                1 (16.6%)                                        
  Interval between fever and convulsion   Less than 24 hours      87 (87%)                                         5 (83.3%)
  More than 24 hours                      13 (13%)                1 (16.6%)                                        
  Laboratory findings                     WBC                     16679 ± 11880 (cell/mm3)                         11986 ± 8842 (cell/mm3)
  PMN                                     52.1 ± 19.3(%)          45 ± 7(%)                                        
  Lymphocyte                              41.1 ± 26.7(%)          47 ± 7(%)                                        
  ESR                                     77 ± 16 (mm/h)          16 ± 6 (mm/h)                                    
  CSF analysis                            WBC (mean ± SD)         130 ± 27 (cell/mm3)                              
  RBC (mean ± SD)                         3450 ± 616 (cell/ ìl)                                                    
  Sugar (mean ± SD)                       62 ± 17 (mg/dl)         57 ± 7 (mg/dl)                                   
  protein (mean ± SD)                     22 ± 30 (mg/dl)         22 ± 14 (mg/dl)                                  
  Encephalitis                                                    0 (0%)                                           0 (0%)
  Complete recovery                                               100 (100%)                                       6 (100%)
